Back to Search
Start Over
Hepatosplenic αβ T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia.
- Source :
-
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Aug; Vol. 42 (6), pp. e463-e465. - Publication Year :
- 2020
-
Abstract
- Ataxia-telangiectasia is a rare autosomal recessive neurodegenerative disease characterized by ataxia, radiosensitivity, telangiectases, and increased risk for hematologic malignancies. We present a case of a female individual diagnosed with T-cell acute lymphocytic leukemia at 13 years and subsequently with αβ subtype of hepatosplenic T-cell lymphoma (HSTCL) at 20 years. During her diagnostic work up for HSTCL, paired tumor-germline sequencing identified a diagnosis of ataxia-telangiectasia. We also describe a very refractory clinical course of her αβ HSTCL, including only a brief response to multiagent chemotherapy and an allogenic bone marrow transplant.
- Subjects :
- Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Female
Humans
Liver Neoplasms drug therapy
Liver Neoplasms etiology
Lymphoma, T-Cell drug therapy
Lymphoma, T-Cell etiology
Neoplasms, Second Primary drug therapy
Neoplasms, Second Primary etiology
Prognosis
Splenic Neoplasms drug therapy
Splenic Neoplasms etiology
Young Adult
Ataxia Telangiectasia complications
Liver Neoplasms pathology
Lymphoma, T-Cell pathology
Neoplasms, Second Primary pathology
Receptors, Antigen, T-Cell, alpha-beta immunology
Splenic Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1536-3678
- Volume :
- 42
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of pediatric hematology/oncology
- Publication Type :
- Academic Journal
- Accession number :
- 31259827
- Full Text :
- https://doi.org/10.1097/MPH.0000000000001537